Capital Flow Patterns in the Life Sciences Industry
Capital flow patterns in the life sciences industry have undergone significant transformation over the past decade, shaped by regulatory evolution, macroeconomic pressures, and shifting innovation cycles. In the United States, capital allocation across biotechnology, medtech, and healthcare services reflects a complex interplay between venture financing, public markets, strategic partnerships, and federal policy frameworks. Knowing these … Read more